• Profile

Hyperuricemia is an important risk factor of the erectile dysfunction: A systematic review and meta-analysis

Andrologia Feb 10, 2022

Findings highlight hyperuricemia as an important risk factor of erectile dysfunction (ED). In hyperuricemia cases, ED risk can be attenuated by urate-lowering therapy (ULT). According to results, hyperuricemia-related endothelial dysfunction could also underlie the pathogenesis of ED in these patients.

  • This systemic review and meta-analysis was conducted to assess the link between hyperuricemia and ED by analyzing five cohort studies and six cross-sectional studies, comprising a total of 454,510 participants.

  • A 1.59-fold higher risk of ED was observed in patients with hyperuricemia vs (pooled odds ratio, OR = 1.59, 95% CI [1.29, 1.97]) the non-hyperuricemia counterparts.

  • In these hyperuricemia patients, ULT decreased ED risk by 27% (OR = 1.27, 95% CI [1.14, 1.41]).

  • Post-subgroup analysis, the link between hyperuricemia and ED continued to be significant apart from the >60 years subgroup.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen